ANI Pharmaceuticals, Inc. (ANIP) on Wednesday said it has launched Isosorbide Mononitrate Tablets, following final approval from the U.S. Food and Drug Administration (FDA).
The product is a generic version of Monoket, a vasodilator indicated for angina pectoris and marketed by Lannett Company.
ANI Pharmaceuticals shares were up more than 7% in pre-market trading after closing at $79.47 on Tuesday.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.